U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Human Drug Advisory Committees
  5. Gastrointestinal Drugs Advisory Committee
  6. Gastrointestinal Drugs Advisory Committee Roster
  1. Gastrointestinal Drugs Advisory Committee

Gastrointestinal Drugs Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info

Current Number of Vacancies = 6
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Chairperson
Benjamin Lebwohl, MD, MS
Expertise: Gastroenterology
Term: 7/1/2017–6/30/2025
Professor of Medicine and Epidemiology
Associate Clinical Chief, Division of Digestive and Liver Diseases
Director of Clinical Research, The Celiac Disease Center
Columbia University College of Physicians & Surgeons
180 Fort Washington Avenue, Suite 936
New York, New York 10032

Designated Federal Officer 
Jessica Seo, PharmD, MPH
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001
Fax: (301) 847-8533
Email: GIDAC@fda.hhs.gov

David N. Assis, MD
Expertise: Hepatology
Term: 4/23/2022–6/30/2025
Yale School of Medicine
Department of Internal Medicine, Section of Digestive Diseases
333 Cedar St, 1080 LMP
New Haven, Connecticut 06510

Lin Chang, MD
Expertise: Gastroenterology
Term: 9/16/2021–6/30/2025
Professor of Medicine
Vice-Chief, Vatche and Tamar Manoukian Division of Digestive Diseases
10833 Le Conte Avenue
David Geffen School of Medicine at UCLA
Los Angeles, California 90095-7378

Christopher S. Coffey, PhD, MS
Expertise: Biostatistics
Term: 6/27/2024–6/30/2026
Professor and Director
Clinical Trials Statistical and Data Management Center
Department of Biostatistics
University of Iowa
145 N. Riverside Drive
Iowa City, Iowa 52242

**Wallace V. Crandall, M.D., M.M.M.
Expertise: Pediatric Gastroenterology, Late Phase Drug Development
Term: 2/28/2024 to 10/31/2027
Associate Vice President – Medical, Immunology
GI Therapeutic Area Head
Eli Lilly and Company
Lilly Corporate Center
Building 88
Indianapolis Indiana, 46285

Theo Heller, MD
Expertise: Hepatology
Term: 9/9/2024 – 6/30/2028
Chief, Translational Hepatology Section
Senior Investigator, Liver Diseases Branch
National Institute of Diabetes and Digestive Kidney Diseases
National Institutes of Health
Building 10, Room 9B16,
10 Center Drive MSC 1800
Bethesda, Maryland 20892

Brian P. Lee, MD, MAS
Expertise: Hepatology
Term: 9/9/2024 – 6/30/2028
Associate Professor of Medicine
Division of Gastrointestinal and Liver Diseases
Keck School of Medicine
University of Southern California
2250 Alcazar Street
Los Angeles, California 90089

*Joy M. McVey, BA
Expertise: Consumer Representative
Term: 3/19/2018–6/30/2025
Program Manager, Volunteer Services
Emory Healthcare
Principal Consultant
Simply Joy, LLC
860 Johnson Ferry Road
Suite 140, #148
Atlanta, Georgia 30342

* Consumer Representative
** Industry Representative (non-voting)

Updated: September 10, 2024

 

Back to Top